These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 18926539

  • 1. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.
    Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Yasuda T, Umayahara Y, Kosugi K, Yamasaki Y.
    Atherosclerosis; 2009 May; 204(1):288-92. PubMed ID: 18926539
    [Abstract] [Full Text] [Related]

  • 2. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
    Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Yasuda T, Yamasaki Y.
    Diab Vasc Dis Res; 2008 Sep; 5(3):190-7. PubMed ID: 18777492
    [Abstract] [Full Text] [Related]

  • 3. Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy.
    Jeong SJ, Kim CO, Song YG, Baek JH, Kim SB, Jin SJ, Ku NS, Han SH, Choi JY, Lee HC, Kim JM.
    Atherosclerosis; 2011 Dec; 219(2):778-83. PubMed ID: 21872861
    [Abstract] [Full Text] [Related]

  • 4. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S, Yamazaki M, Murakami H, Maruyama K, Uchiyama S.
    J Stroke Cerebrovasc Dis; 2014 Dec; 23(10):2540-2546. PubMed ID: 25282185
    [Abstract] [Full Text] [Related]

  • 5. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
    Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, Ohtoshi K, Hayaishi-Okano R, Kosugi K, Hori M, Yamasaki Y.
    Diabetes Care; 2005 Nov; 28(11):2716-21. PubMed ID: 16249545
    [Abstract] [Full Text] [Related]

  • 6. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.
    Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y.
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2587-93. PubMed ID: 16224056
    [Abstract] [Full Text] [Related]

  • 7. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T, Tanimoto M, Moon JY, Gotoh H, Aoki T, Matsumoto M, Shibata T, Ohsawa I, Funabiki K, Tomino Y.
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, Kang SW, Choi KH, Kim HJ, Yoo TH.
    Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
    [Abstract] [Full Text] [Related]

  • 9. Association between sRAGE, esRAGE levels and vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.
    Yang SJ, Kim S, Hwang SY, Kim TN, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM.
    Atherosclerosis; 2012 Feb; 220(2):402-6. PubMed ID: 22137663
    [Abstract] [Full Text] [Related]

  • 10. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
    Saito R, Araki S, Yamamoto Y, Kusuhara K.
    J Pediatr Endocrinol Metab; 2017 Jan 01; 30(1):63-69. PubMed ID: 27941172
    [Abstract] [Full Text] [Related]

  • 11. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.
    Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K.
    Cardiovasc Diabetol; 2015 Sep 25; 14():126. PubMed ID: 26408307
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients.
    Peng WH, Jian WX, Li HL, Hou L, Wei YD, Li WM, Xu YW.
    Cardiovasc Diabetol; 2011 May 18; 10():41. PubMed ID: 21592353
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carotid intima-media thickness and risk of cardiovascular events in high-risk patients. Results of the Osaka Follow-Up Study for Carotid Atherosclerosis 2 (OSACA2 Study).
    Kitagawa K, Hougaku H, Yamagami H, Hashimoto H, Itoh T, Shimizu Y, Takahashi D, Murata S, Seike Y, Kondo K, Hoshi T, Furukado S, Abe Y, Yagita Y, Sakaguchi M, Tagaya M, Etani H, Fukunaga R, Nagai Y, Matsumoto M, Hori M, OSACA2 Study Group.
    Cerebrovasc Dis; 2007 May 18; 24(1):35-42. PubMed ID: 17519542
    [Abstract] [Full Text] [Related]

  • 19. Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia.
    Halenka M, Vaverkova H, Hutyra M, Karasek D, Slavik L, Novotny D, Krskova M.
    Int Angiol; 2004 Sep 18; 23(3):230-7. PubMed ID: 15765037
    [Abstract] [Full Text] [Related]

  • 20. Ten-year time course of risk factors for increased carotid intima-media thickness: the Hoorn Study.
    van den Berg E, Biessels GJ, Stehouwer CD, Kappelle LJ, Heine RJ, Nijpels G, Dekker JM.
    Eur J Cardiovasc Prev Rehabil; 2010 Apr 18; 17(2):168-74. PubMed ID: 19940777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.